THE HIT SONGS THAT TURNED SHREYA GHOSHAL INTO A SUPERSTAR
by ASJAD NAZIR
MARCH belongs to Shreya Ghoshal because she turns a year older and commences another blockbuster UK tour.
The undisputed queen of Bollywood music has won countless awards and delivered timeless classics that will entertain generations to come. She has shown an incredible versatility with a natural singing ability in diverse languages and genres.
Eastern Eye decided to celebrate Shreya’s birthday with an ultimate playlist that includes a hit for every year of her 18-year professional career...
2002: Shreya was just a teenager when she was introduced to the world with stunning songs in mega-blockbuster Devdas. Although Dola Re Dola is regarded as one of the all-time great dance numbers, Bairi Piya was a technically brilliant track that won her a National Award and was the standout moment of 2002.
2003: The sensual Jaadu Hai Nasha Hai from Jism won Shreya a Filmfare Award for Best Female Playback singer and would help fast-track her to the top of the Bollywood tree. The song still remains popular and can often be heard at her sell-out live performances.
2004: By 2004 Shreya was doing a wide array of projects and lit up pop album Tera Mera Pyar with incredible songs, including the mesmerising Yeh Kya Hua. The romantic number filled with feeling was better than any film song she did that year and still captures the imagination.
2005: Shreya won a National Award for dynamic duet Dheere Jalna from Paheli, but the beautiful Agar Tum Mil Jao was a better song that touched the hearts of listeners. The love song got a Filmfare Award nomination, but deserved so much more.
2006: Although in Bollywood she delivered Lage Raho Munnabhai romantic number Pal Pal Har Pal, which gained award nominations, the stand-out song was Munbe Vaa from Sillunu Oru Kaadhal. The Tamil song won her a Filmfare South Award and the versatile singer recorded the same number in Telugu.
2007: Shreya won a Filmfare Best Female Playback singer award for Barso Re from Guru, but went one better with a prestigious National Award for Jab We Met song Yeh Ishq Haye. The fun song from the romantic road movie was filled with a positive energy that connected with Bollywood fans globally.
2008: The year included love song Tujh Mein Rab Dikhta Hai from Rab Ne Bana Di Jodi, but the duet Teri Ore from Singh Is Kinng captured everyone’s imagination and won Shreya a load of awards. The song with Rahat Fateh Ali Khan became one of the biggest Bollywood hits of all-time.
2009: The standout musical moment in record-breaking Bollywood film 3 Idiots was Shreya’s duet with Sonu Nigam, Zoobi Doobi. But Shreya’s big highlights of 2009 were Pherari Mon from Bengali film Antaheen and Jeev Rangla from Marathi film Jogwa – The Awakening. The songs won her another National Award.
2010: The beautiful Bahara from I Hate Luv Storys had the perfect combination of romance and fun. The vocal delivery was able to mix up a feeling of love with other emotions like friendship and was the best moment in the film.
2011: Shreya has delivered incredible duets across the years, and another amazing one was Teri Meri from Bodyguard. The link-up with Rahat Fateh Ali Khan helped turn the movie into a super-hit and resulted in more glory for Shreya.
2012: The haunting Saans from Jab Tak Hai Jaan won awards, but Chikni Chameli from Agneepath showed off a whole other side to Shreya’s repertoire. The dynamite dance number proved quite comprehensively there is more to her than just slow emotion-filled love songs.
2013: The undisputed queen of Bollywood delivered the explosive Nagada Sang Dhol from Goliyon Ki Raasleela Ram-Leela, but demonstrated once again that no one does love songs better with the stunning Sun Raha Hai from Aashiqui 2. The love song connected with anyone who has ever been in love and became an anthem.
2014: The singer continued to deliver big songs in various languages, but the undisputed highlight of 2014 was her superb ghazal album Humnasheen. She delivered timeless classics and showed off her incredible vocal range with tracks that connected different generations. The album was so good that we can’t single out just one song.
2015: The actress has had a dream team partnership with film director Sanjay Leela Bhansali since the beginning of her career, and they delivered again with Deewani Mastani from Bajirao Mastani. The wonderful song won Shreya another Filmfare Award and again showed her technical brilliance.
2016:Singaar Ko Rehne Do was a mesmeric song that featured on the stunning album Gulzar In Conversation With Tagore. This was one of six beautiful compositions Shreya sang on the LP, which saw legendary lyricist Gulzar translate six poems and one song by Rabindranath Tagore into Hindi.
2017:Dhadkane Azad Hain is the first fully independent single delivered by Shreya and had her trademark vocal brilliance. The track was another major turning point for the boundary-breaking singer, who found the middle ground between classical and commercial music.
2018: The Shreya Ghoshal-Sanjay Leela Bhansali partnership delivered again with the beautiful Ghoomar from Padmaavat, which won her another Filmfare Award. The song was a real work of art.
2019: There are few singers in the history of Bollywood who could have taken on the technically-difficult Ghar More Pardesiya, but Shreya did it effortlessly. The best song of 2019 deservedly won multiple awards and once again raised the bar in Bollywood.
2020: It is too early in 2020 to pick a magical moment for Shreya, but the queen of Bollywood music looks like she will rule for years to come. She will undoubtedly deliver more mesmerising hits.
Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
A new discount deal with UK suppliers will limit the increase for patients.
Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
NHS pricing remains unaffected due to separate arrangements.
Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.
Why the price rise was announced
Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.
Discount deal for UK suppliers
The revised agreement will see the top-dose price set at £247.50 for suppliers. While pharmacies and private providers will still add their own margins, the increase for patients is now likely to remain under 50% for higher doses, and even lower for smaller doses.
Eli Lilly confirmed:
“We are working with private providers on commercial arrangements to maintain affordability and expect these to be passed onto patients when the change is effective on 1 September.”
Impact on consumers
Around 1.5 million people in the UK are currently on weight-loss drugs, with more than half using Mounjaro. Most of these patients—around 90%—pay privately through online services or high street pharmacies.
Prices vary between providers, depending on the level of lifestyle and dietary support offered alongside the injections.
Olivier Picard of the National Pharmacy Association said:
“This rebate will mitigate some of the impact of the increase, but patients should still anticipate seeing a rise in prices from 1 September.”
NHS pricing unchanged
The deal does not affect the NHS, which has secured its own heavily-discounted price for patients prescribed the weekly injection.
Mounjaro works by helping patients feel fuller for longer, reducing food intake and supporting weight loss of up to 20% of body weight.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)
CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.
GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.
The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. Research estimates chickenpox in childhood leads to £24 million in lost income and productivity annually.
Minister of State for Care, Stephen Kinnock, said: “We’re giving parents the power to protect their children from chickenpox and its serious complications, while keeping them in nursery or the classroom where they belong and preventing parents from scrambling for childcare or having to miss work. This vaccine puts children’s health first and gives working families the support they deserve. As part of our Plan for Change, we want to give every child the best possible start in life, and this rollout will help to do exactly that.”
Dr Gayatri Amirthalingam, Deputy Director of Immunisation at the UK Health Security Agency, said: “Most parents probably consider chickenpox to be a common and mild illness, but for some babies, young children and even adults, chickenpox can be very serious, leading to hospital admission and tragically, while rare, it can be fatal. It is excellent news that from next January we will be introducing a vaccine to protect against chickenpox into the NHS routine childhood vaccination programme – helping prevent what is for most a nasty illness and for those who develop severe symptoms, it could be a life saver.”
Amanda Doyle, National Director for Primary Care and Community Services at NHS England, said: “This is a hugely positive moment for families as the NHS gets ready to roll out a vaccine to protect children against chickenpox for the first time, adding to the arsenal of other routine jabs that safeguard against serious illness.”
The eligibility criteria will be set out in clinical guidance, and parents will be contacted by their GP surgery if their child is eligible.
WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.
Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.
“For so long, so many women haven’t been listened to by the world of medicine,” Munchetty said. “I knew this from my own experience of not being given adequate pain relief, or waiting years for a diagnosis. My motivation was to help women and people who love women to advocate better for women’s health.”
The book blends Munchetty’s personal journey with the voices of other women who have faced similar struggles, alongside expert insights from medical professionals. Its purpose, she said, is clear: to empower people to fight for their health.
“We need to be unafraid of saying how we have been weakened by our symptoms,” the BBC presenter said.
“Too often, we try to keep afloat, keep our head above water, but we don’t want to seem weak. That needs to change.”
Munchetty’s candour is striking. She describes the shame of being told her excruciating periods were “just normal,” leaving her to feel weak and whiny for struggling.
“You might as well have told me people have heart attacks while I’m having a heart attack,” she said. “Debilitating pain is serious — it may not be lifelimiting, but it is life-impacting.”
Her determination to challenge that culture led to her giving evidence in parliament, contributing to what became a Women and Equalities Committee report, published in December 2024.
The report made headlines for its stark conclusion: medical misogyny exists.
For Munchetty, seeing that phrase in black and white was transformative. “It was almost self-affirming,” she said. “We now know it’s there, so we can challenge it. Women can say: I know my body, I know there’s not enough research, and I am entitled to push for answers.”
The parliamentary report went further than acknowledgement. It called for ring-fenced funding for women’s health hubs, better training for GPs, and greater investment in research into reproductive conditions like adenomyosis and endometriosis.
It highlighted how symptoms are routinely dismissed as “normal,” delaying diagnosis and disrupting women’s careers, education and daily lives. Munchetty wrote in her book — referencing the report — that medical misogyny is not about blaming individual doctors, but about challenging a system built on insufficient research into women’s bodies.
“It gives women the language and the confidence to not just be heard, but to insist on being taken seriously,” she wrote.
Her book also tackles the additional barriers faced by women from minority communities, who may be discouraged by stigma or embarrassment from speaking about menstruation or menopause. To them, Munchetty has a clear message: “You are so much more valuable than you realise. If you don’t prioritise your health, you are lessening your ability to hold up everyone around you.”
Those featured in the book are friends, colleagues, charities and everyday women who contributed their stories, many for the first time. “I was surprised at how many friends are in that book with such powerful experiences,” Munchetty said.
“It told me all the more that we’re not speaking about it, and that it is sadly so very common.”
At a launch event for the book, contributors, family and experts filled the room with what Munchetty describes as an “electric and inspiring atmosphere.”
She said, “It was full of joy, of women who felt safe to speak up and be heard. This is not a whiny book — it’s a positive book. People felt they were part of making things better, part of this women’s health revolution.”
For Munchetty, writing the book was exhausting, but transformative, she said.
“I never thought I’d be an author. I’m a journalist. But this is journalism — facilitating people’s stories to be told powerfully and truthfully. People trusted me, and I’m proud of that.”
And Munchetty’s aim is for the book to be a tool for change: arming women with the language, confidence and strategies to advocate for their health.
“It’s not easy to admit you need help, and it’s not instinctive for women to prioritise themselves,” she said. “But this book will help you do that. It’s the silent friend who has your back and gives you strength.”
It’s Probably Nothing - Critical Conversations on the Women’s Health Crisis is now available in all good bookshops
The Shree Kunj Bihari Vrindavan (UK) Temple has officially launched its project to establish a grand home for Shree Banke Bihari in London.
The inaugural event, held in Harrow from 4 pm, featured devotional chants, the Deep Pragtya ceremony, and a presentation outlining the temple’s vision. Speaking at the gathering, Shalini Bhargava described the planned temple as “a spiritual home promoting bhakti, unity and seva for generations to come.”
Several dignitaries were honoured at the ceremony, including Cllr Anjana Patel, Mayor of Harrow; Anuradha Pandey, Hindi and Cultural Attaché at the High Commission of India; Kamakshi Jani of the Royal Navy; Councillors Janet Mote, Nitin Parikh and Mina Parmar; Krishnaben Pujara, Chairperson of ALL UK; and Truptiben Patel, President of the Hindu Forum of Britain.
Organisers said the launch marks the beginning of a new spiritual and cultural hub for London’s Hindu community, offering a centre for devotion, learning and community service.
Martin Dickie has announced his departure from BrewDog and the alcohol industry.
He co-founded the Ellon-based brewer with James Watt in 2007.
Dickie cited family time and personal reasons for his exit.
His departure follows recent bar closures as part of a company restructuring.
BrewDog confirmed no further leadership changes will follow.
BrewDog co-founder Martin Dickie has announced he is leaving the Scottish brewer and the wider alcohol industry for “personal reasons.” Dickie, who founded the Ellon-based business with James Watt in 2007, said he wanted to spend more time with his family after more than two decades in brewing and distilling.
Early beginnings
Dickie and Watt launched BrewDog at the age of 24, starting from a garage in Fraserburgh and selling hand-filled bottles from a van at local markets. The company grew rapidly to become one of the UK’s best-known craft brewers.
Leadership changes
James Watt stepped down as chief executive last year after 17 years in the role, moving into a non-executive position as “captain and co-founder.” Dickie’s exit marks another major shift in the company’s founding leadership.
Dickie’s statement
“Leaving BrewDog isn’t easy, but I’m ready to spend less time travelling and spend some more time at home with my young family,” Dickie said. He added: “It has been an honour to have worked with incredible, like-minded colleagues who live in a world of flavour and experimentation. In James Taylor and Lauren Carrol, BrewDog is in very strong hands and I will always remain a massive fan.”
Company response
BrewDog chief executive James Taylor praised Dickie’s contribution, highlighting his focus on product quality, workplace safety, sustainable supplier relationships, and new product development. “Martin’s contributions to BrewDog have been immeasurable,” Taylor said. “His creativity, passion, and relentless drive have shaped our company over the years and inspired countless others in the industry.”
Recent challenges
The announcement comes a month after BrewDog closed ten of its bars, including its flagship Aberdeen Gallowgate site and a Dundee outlet, citing commercial unviability. The company stressed that Dickie’s departure will not result in further leadership changes.